A compact agreement has been developed by the Association of the British Pharmaceutical Industry (ABPI) and NHS England to ensure effective partnership working between ABPI member companies and Specialised Services Clinical Reference Groups (CRGs).
The agreement highlights a number of commitments from both parties that will enable them to work collaboratively to drive the delivery of high quality treatments and services to add value to patients.
Examples of what CRGs can expect from a partnership with pharmaceutical organisations include:
The creation of a new industry group tasked with developing the strategic partnership
Help to identify where quality and productivity efficiencies can be made on pathways of care
Support implementation of service policies where appropriate, and the adoption of new medicines
Examples of what pharmaceutical organisations can expect from a partnership with CRGs include:
Involvement in the formation of clinical access policy development that relates to their product or specifications to a field of interest
A single point of contact for each CRG
Effective and timely clinical expertise into NHS England evaluation processes
Commenting on the agreement, ABPI NHS Partnership Director, Carol Blount, said:
“The pharmaceutical industry welcomes the opportunity to look at new and improved ways of working with CRGs, and we are committed to making the compact agreement work. Allowing the pharmaceutical industry and CRGs to work more effectively and creatively together on services will help ensure that patients living with diseases or disorders, that are rare or dealt with by a specialised team, have the best access to the treatments they need.”
ABPI Press Office
Tel: +44 (0) 20 7747 1441
Mobile: +44 (0) 7850 312064
Email: [email protected]